Comparative review of anastrozole, letrozole and exemestane in the management of early breast cancer

Author： Nabholtz Jean-Marc   Mouret-Reynier Marie-Ange   Durando Xavier   Van Praagh Isabelle   Al-Sukhun Sana   Ferriere Jean-Pierre   Chollet Philippe  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.9, 2009-06, pp. : 1435-1447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A review of exemestane in the management of breast cancer

By Wong Nan Soon   Pritchard Kathleen I  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 13, 2005-10 ,pp. : 2353-2363

Informa Healthcare

Access to resources Recommend Favorite

Anastrozole: In Early Breast Cancer

By Wellington K.   Faulds D.M.  

Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. : 2485-2492

Adis International

Access to resources Recommend Favorite

Anastrozole in the management of breast cancer

By Reese David   Nabholtz Jean-Marc  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 9, 2002-09 ,pp. : 1329-1339

Informa Healthcare

Access to resources Recommend Favorite

Exemestane in postmenopausal women with early or advanced breast cancer: a review

By Bertelli Gianfilippo   Gangadhara Sharath  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1933-1942

Informa Healthcare

Access to resources Recommend Favorite

Estrogen receptor modulators: Colorectal cancer (first report for anastrozole, exemestane and letrozole): 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1301, 2010-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite